Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Sotos syndrome is estimated to affect between 1 in 10,000 and 1 in 50,000 individuals worldwide, though exact figures are difficult to determine due to frequent underdiagnosis. As a rare genetic condition characterized by overgrowth, Sotos syndrome is typically identified in early childhood and affects both males and females with equal frequency across all ethnic populations. What is the estimated prevalence and incidence of Sotos syndrome? Determining the exact prevalence of Sotos syndrome is challenging because mild cases may go undiagnosed or be misattributed to other developmental disorders.
TL;DR: Sotos syndrome is estimated to affect between 1 in 10,000 and 1 in 50,000 individuals worldwide, though exact figures are difficult to determine due to frequent underdiagnosis. As a rare genetic condition characterized by overgrowth, Sotos syndrome is typically identified in early childhood and affects both males and females with equal frequency across all ethnic populations.
Determining the exact prevalence of Sotos syndrome is challenging because mild cases may go undiagnosed or be misattributed to other developmental disorders. Current clinical estimates suggest a prevalence ranging from 1 in 10,000 to 1 in 50,000 live births. Because Sotos syndrome is a rare genetic disorder, accurate incidence rates—the number of new cases per year—are not tracked by global registries, though it is recognized as a rare condition rather than an ultra-rare one. Within the DiseaseMaps.org community, 98 people with Sotos syndrome have connected to share their experiences, reflecting the global reach of this rare diagnosis.
Clinical data indicates that Sotos syndrome affects males and females with equal frequency. There is no evidence in current medical literature to suggest that any specific ethnic, racial, or geographic population is at a higher risk of developing the condition. Because the underlying cause is typically a de novo (new) mutation in the NSD1 gene, the occurrence is sporadic and does not follow patterns of ancestry or environmental exposure.
The primary hurdle in gathering accurate data on Sotos syndrome is the wide spectrum of clinical presentation. Many individuals with milder physical features or less severe intellectual disability may never receive a formal genetic confirmation. Furthermore, the diagnostic criteria for Sotos syndrome have evolved over time; as genetic testing becomes more accessible, we expect that prevalence estimates may be adjusted to reflect those previously missed by clinical observation alone. The following factors complicate current epidemiological data:
Sotos syndrome is considered a pediatric-onset condition, as the most hallmark features—such as rapid growth in height, macrocephaly (large head size), and characteristic facial features—are most apparent during early childhood. While the physical overgrowth often slows down during adolescence, the developmental and cognitive impacts persist into adulthood. Consequently, while the diagnosis is most often made in the first few years of life, many adults are currently living with Sotos syndrome, benefiting from long-term management strategies.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of your physician or qualified health provider with any questions regarding a medical condition.